SCHEMBL5377330

SCHEMBL5377330

Cc1ccc(Cc2ccc(=O)[nH]n2)cc1C(=O)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.52
PARP1 P09874 12/20 0.39
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
PSMB11 A5LHX3 1/20 0.33
PSMA7 O14818 1/20 0.33
PSMB1 P20618 1/20 0.33
PSMA1 P25786 1/20 0.33
PSMA2 P25787 1/20 0.33
PSMA3 P25788 1/20 0.33
PSMA4 P25789 1/20 0.33
PSMB8 P28062 1/20 0.33
PSMB9 P28065 1/20 0.33
PSMA5 P28066 1/20 0.33
PSMB4 P28070 1/20 0.33
PSMB6 P28072 1/20 0.33
PSMB5 P28074 1/20 0.33
PSMB10 P40306 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373711 0.91 CYP3A4 (0.49) CYP3A4PARP1MEN1NPC1RAB9A
SCHEMBL5368972 0.90 CYP3A4 (0.64) CYP3A4PARP1NPC1RAB9A
SCHEMBL5371246 0.86 CYP3A4 (0.48) CYP3A4PARP1MEN1NPC1RAB9A
SCHEMBL5373848 0.80 CYP3A4 (0.54) CYP3A4PARP1MEN1NPC1RAB9A
SCHEMBL5368912 0.77 CYP3A4 (0.83) CYP3A4PARP1
SCHEMBL5370322 0.76 CYP3A4 (0.53) CYP3A4PARP1KMT2A
SCHEMBL5374280 0.76 CYP3A4 (0.50) CYP3A4KMT2ACNR2
SCHEMBL5367001 0.74 MAPT (0.45) CYP3A4PARP1MEN1NPC1RAB9A
SCHEMBL7583539 0.74 CYP3A4 (0.42) CYP3A4MEN1NPC1RAB9AKMT2A
SCHEMBL5368836 0.73 CYP3A4 (0.64) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed